Mark Kiel

Mark Kiel

Company: Genomenon Inc.

Job title: Chief Scientific Officer

Seminars:

Fireside Chat: Harnessing the Genomics of Cancer: What Can We Learn from Orphan Drug Developers? 3:00 pm

Is it time to treat cancer as a rare disease? Meet us at the intersection of cancer and orphan drug development for a candid discussion on how evolving genomic approaches for rare diseases can help advance clinical biomarker discovery and companion diagnostics for cancer precision medicines.Read more

day: Day 1 Track C PM

VENUE

Omni Boston Hotel at the Seaport
450 Summer Street
Boston, MA, 02210

LOCATION

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences Beacon
Searchlight Intelligence

SEARCH

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.